Newsroom

Sorted by: Latest

-

Sensorion Announces its Participation in the European Society of Gene & Cell Therapy (ESGCT) Annual Congress

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) (“the Company”), a pioneering clinical-stage biotechnology company that develops novel therapies to restore hearing and to treat and prevent hearing loss disorders, today announced its participation in the 33rd European Society of Gene & Cell Therapy (ESGCT) Annual Congress, taking place on October 27-30, 2026, at the Congress Center Hamburg (CCH), in Hamburg, Germany. Lise Barrot, Pre...
-

Sensorion annonce sa participation au Congrès Annuel de la Société Européenne de Thérapie Génique et Cellulaire (ESGCT)

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR001401A9Z0 – ALSEN) (« la Société »), société de biotechnologie pionnière au stade clinique qui développe de nouvelles thérapies visant à restaurer l’audition ainsi qu’à traiter et prévenir les troubles liés à la perte auditive, annonce aujourd’hui sa participation au 33e Congrès annuel de la Société Européenne de Thérapie Génique et Cellulaire (ESGCT), qui se tient du 27 au 30 octobre 2026 au Congress Center...
-

Rémy Cointreau: First-Half Sales up +2.9% on an Organic Basis1

PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO) generated first-half 2026-27 sales of €510.9 million, up +2.9% organically. On a reported basis, sales rose by +4.4%, including a positive currency effect of +1.5% mainly reflecting the appreciation of the renminbi, partly offset by a slight weakness in the dollar. Sales in the Americas recorded a -5.5% decline, due primarily to a high basis of comparison for cognac and destocking in the United States following changes in distr...
-

Rémy Cointreau : Chiffre d’affaires en hausse de +2,9% en organique1 au premier semestre

PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO) a réalisé un chiffre d’affaires de 510,9 millions d’euros au premier semestre 2026-27, en progression de +2,9% en organique. En données publiées, le chiffre d’affaires a augmenté de +4,4%, intégrant un effet de change favorable de +1,5%, principalement lié à l’appréciation du renminbi, partiellement atténué par un impact encore légèrement négatif du dollar. La région Amériques a enregistré un recul de ses ventes de -5,5%, princ...
-

Ant International CEO: Achieving Inclusion Is Critical to Re-Globalisation, and AI Will Accelerate It by Democratising Opportunities

DOHA, Qatar--(BUSINESS WIRE)--Speaking at the United Nations Trade and Development (UNCTAD) World Investment Forum 2026 panel, “Investing in AI for an Inclusive Digital Future”, Ant International CEO Peng Yang called for a new, inclusive “re-globalisation” project that harnesses AI and digital connectivity to give small and medium-sized enterprises (SMEs) greater access to global markets and opportunities. “Globalisation 1.0 mostly benefited large enterprises, and a lot of SMEs very rarely got...
-

Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)--Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced it has completed the acquisition of ArisGlobal and is now uniting its Life Sciences and Healthcare capabilities into a unified AI platform that connects science, medicine and patients. The milestones advance its ambition to improve people’s lives by empowering faster drug discovery, better therapies and smarter decisions. Dr. Ashwini Zenooz has been appointed Executive Vice Pre...
-

Parade Technologies Reports Third Quarter 2026 Financial Results

SAN JOSE, Calif.--(BUSINESS WIRE)--Parade Technologies Reports Third Quarter 2026 Financial Results...
-

Materialise Reports Third Quarter 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the third quarter ended September 30, 2026. Highlights – Third Quarter 2026 Total revenue increased by 2.1% to 67,670 kEUR for the third quarter of 2026 compared to 66,259 kEUR for the corresponding 2025 period. Excluding last year’s revenue for the recen...
-

Product Launch of NIL Technology’s Award-Winning metaEye™, World's First All Meta-Optics Camera

COPENHAGEN, Denmark--(BUSINESS WIRE)--Product launch of NIL Technology’s award-winning metaEye™, world's first all meta-optics camera....
-

UBS reports 3Q26 net profit of USD 2.7bn and 14.8% RoCET1, continued strong client momentum and disciplined execution across businesses (Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules)

ZURICH--(BUSINESS WIRE)--Regulatory News: UBS (NYSE:UBS) (SWX:UBSN): “In an increasingly complex market environment, our strong third-quarter performance once again demonstrated the benefits of our diversified global business model and disciplined execution.“ “The breadth and depth of our global franchise and our unwavering commitment to serving our clients were reflected in robust client momentum, including USD 55 billion of net new assets in Global Wealth Management, with particularly strong...